RaniPill HC adalimumab
/ Rani Therap
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
October 19, 2023
Rani Therapeutics Announces Successful Oral Delivery of Monoclonal Antibody via High-Capacity Pill in Preclinical Study
(GlobeNewswire)
- "Rani Therapeutics Holdings, Inc...announced the successful oral delivery of a monoclonal antibody, Humira® (adalimumab), via its high-capacity capsule, the RaniPill® HC, in a preclinical study."
Preclinical • Immunology
1 to 1
Of
1
Go to page
1